You are an expert Named Entity Recognition (NER) system. Label all identifiable…
- User
System: You are an expert Named Entity Recognition (NER) system. Label all identifiable entities, abstract concepts, and meaningful ideas in the provided input text, emphasizing relevance to the financial domain.
Ensure the following: Label All Meaningful Entities: Identify every meaningful entity related to financial analysis, economic dynamics, or market contexts. Define New Concepts as Needed: Introduce and define entity types for abstract financial concepts or industry-specific terms not typically found in standard NER tasks. Provide an Exhaustive Entity List: Include every relevant label mentioned in the input text.
Answer in the following format: | | <description of entity group/concept>, | | <description of entity group/concept>, ...
Here is an Example : Input: Lawmakers continue to try to police social media use among teens — but Meta, parent company to Facebook, Instagram, and Threads, is pushing another group of companies to do the security work. Meta is expected to announce a proposal on Nov. 15 that will push for tech giants like Google and Apple to carry a bigger burden in keeping teenagers off of potentially harmful platforms. Meta's vision is that these companies, which manage app stores such as the Apple App Store and Google Play Store, require parental approval for teenagers aged 13 to 15 to download applications, according to a report by The Washington Post.
Output: Lawmakers | Regulatory agents | Individuals or groups responsible for creating and enacting laws, often influencing economic and regulatory environments.
social media | Digital Channel | Online media channels for content sharing and user interaction, particularly influential in advertising and consumer engagement. Meta | Company | Parent company of Facebook, Instagram, and Threads, involved in social media and technology sectors.
Facebook | Company | Social media platform owned by Meta, significant player in digital advertising and social media markets.
Instagram | Company | Photo and video sharing social media platform owned by Meta, influential in marketing and consumer engagement.
Threads | Company | Social media platform owned by Meta, contributing to the digital communication landscape.
Nov. 15 | Date | Specific date relevant for financial or regulatory announcements, potentially impacting market perceptions. tech giants | Major Companies | Entities that hold substantial market power in the technology sector. Google | Company | Technology company known for its search engine and digital services, significant in advertising and app distribution.
Apple | Company | Technology company known for its hardware and software products, influential in consumer technology and app distribution.
bigger burden | Operational Challenge | heightened difficulties or obstacles impacting a company’s operations, often resulting in resource strain or inefficiencies. Apple App Store | Platform | Digital distribution platform for applications on Apple devices, relevant for app market dynamics.
Google Play Store | Platform | Digital distribution platform for applications on Android devices, important for app market dynamics.
Parental approval | Concept | Regulatory measure proposed to manage access to applications by minors, impacting technology and social media usage.
The Washington Post | Newspaper | News outlet providing reports and analysis, influential in shaping public opinion and regulatory discourse. User: KEY POINTS: A Johnson & Johnson pharmaceutical unit focused on the development of hepatitis C research said it will end its program amid a crowded market. Janssen Sciences Ireland cited the increasing availability of a number of highly effective therapies addressing the medical need. Shares of biotech company Achillion Pharmaceuticals were more than 20 percent lower Monday in premarket trading after it announced its hepatitis C collaboration with a Johnson & Johnson pharmaceutical unit ended. Johnson & Johnson was down slightly in premarket trading after its Janssen Sciences Ireland said it would discontinue further development of the investigational hepatitis C treatment regimen JNJ-4178 amid a crowded market. Janssen said there is an increasing availability of a number of highly effective therapies addressing the medical need. Hepatitis C is a contagious liver disease which affects about 3.2 million Americans, according to the Centers for Disease Control and Prevention. In a statement Monday, Achillion President and CEO Milind Deshpande said he was "disappointed" by the Janssen decision, given the positive data presented in a recent study. Ongoing phase two studies with JNJ-4178 will be completed as planned, Janssen said in a statement, but will cease thereafter. "Going forward, our hepatitis R&D efforts Assistant: - Assistant
Johnson & Johnson | Company | Multinational corporation specializing in medical devices, pharmaceuticals, and consumer health products. pharmaceutical unit | Business Division | A subdivision within a company focused on drug development and research. Janssen Sciences Ireland | Subsidiary | Johnson & Johnson's pharmaceutical research subsidiary specializing in developing treatments for diseases such as hepatitis C. hepatitis C | Medical Condition | A liver disease caused by the hepatitis C virus, relevant for pharmaceutical market dynamics. market | Economic Concept | The competitive environment in which companies operate, particularly relevant in sectors like pharmaceuticals where multiple treatments might exist. Shares | Financial Instrument | Units of ownership in a company, tradable on public markets like stock exchanges. Achillion Pharmaceuticals | Company | A biotechnology firm involved in developing treatments, particularly for hepatitis C. premarket trading | Financial Term | The period before the regular market session when stock trading can occur, influencing stock prices. collaboration | Business Strategy | Joint efforts between companies to achieve shared business goals, significant for development and financial outcomes in pharmaceutical ventures. investigational hepatitis C treatment regimen JNJ-4178 | Drug Development | A specific therapy under study aimed at treating hepatitis C, significant in pharmaceutical research. Centers for Disease Control and Prevention (CDC) | Government Agency | U.S. federal agency focused on public health and disease prevention. Milind Deshpande | Person | President and CEO of Achillion Pharmaceuticals, representing corporate leadership. phase two studies | Clinical Trial Stage | A stage in clinical research to assess the efficacy and side effects of a drug on patients.